Status:
RECRUITING
Treatment of Rumination
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Conditions:
Rumination Syndrome
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Background: Rumination syndrome is characterized by the involuntary regurgitation of previously ingested food from the stomach to the mouth, triggered by an unintentional contraction of the abdominal ...
Eligibility Criteria
Inclusion
- Rumination syndrome
Exclusion
- Relevant organic diseases
Key Trial Info
Start Date :
May 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06971354
Start Date
May 2 2025
End Date
October 1 2026
Last Update
July 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vall d'Hebron Research Institute
Barcelona, Spain, 08035